Drug intelligence / Profile preview

Jiuwei Gujin

Development stage: Unknown
Lead developer: Shanxi Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Jiuwei Gujin is a Traditional Chinese Medicine (TCM) formulation developed by the Shanxi Traditional Chinese Medical Hospital, primarily used for the treatment of stable-stage chronic obstructive pulmonary disease (COPD). Formulated as a capsule, it is specifically indicated for patients exhibiting the TCM syndrome of "deficiency of lung and kidney." The preparation aims to tonify these organ systems to improve respiratory symptoms, enhance physical capacity, and boost the overall quality of life. It is frequently evaluated in clinical settings alongside pulmonary rehabilitation and exercise interventions.

Brand names: Jiuwei Gujin capsule
Other names: Jiuwei Gujin jiaonang九味固金胶囊

Beyond the preview

Go deeper on Jiuwei Gujin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiuwei Gujin.

Explore the full profile